Antibody Technologies Market Research Reports & Industry Analysis
Antibody technologies involve the use of specialized proteins called antibodies to target and detect specific molecules, often used in medical diagnostics, therapeutics, and research. This field is evolving quickly due to scientific advancements and the growing demand for personalized treatments. To help you stay updated on the latest developments, MarketResearch.com offers a comprehensive collection of reports on antibody technologies.
Valuable Antibody Technologies Research and Analysis
- Find detailed data on various market segments including precision medicine, biosimilars, biologics, protein engineering, and more.
- Obtain antibody technologies market sizing and growth projections, discussions of key drivers and challenges, pricing and regulatory analysis, and company profiles.
- Read expert commentary on recent technological innovations and industry trends to gain a clear understanding of emerging opportunities.
Your Research Partner
Whether you're an experienced industry professional, a consultant, or a busy executive, our antibody technologies market research reports are designed to help you make informed decisions. With reliable data and thorough analyses, these reports support your decision-making process. By choosing MarketResearch.com, you can gain the intelligence needed to stay competitive and take advantage of new opportunities.
Antibody Technologies Industry Research & Market Reports
-
Systemic Radiotherapy
... at a CAGR of 3.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$919.6 Million by the end of ... Read More
-
Custom Antibody
... CAGR of 9.0% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$320.3 Million by the end of the analysis ... Read More
-
Global Bispecific Antibody Therapeutic Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various market segments, while the ... Read More
-
Neuroscience Antibodies and Assays
... reach US$9.8 Billion by 2030, growing at a CAGR of 8.9% over the analysis period 2023-2030. Immunochemistry / Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 9.8% CAGR ... Read More
-
HER2 Antibodies
... at a CAGR of 7.3% over the analysis period 2023-2030. Trastuzumab, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$20.5 Billion by the end of the ... Read More
-
Plasma Protein Therapeutics
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Albumin, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$9.3 Billion by the ... Read More
-
Immunoprecipitation
... 5.7% over the analysis period 2023-2030. Reagents Component, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$457.9 Million by the end of the analysis period. Growth ... Read More
-
Subcutaneous Immunoglobulin
... CAGR of 13.7% over the analysis period 2023-2030. Primary Immunodeficiency Diseases Application, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$12.0 Billion by the end of ... Read More
-
Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029
... Macular Degeneration (AMD) Drugs market is projected to reach USD 17.37 Billion from 2029 USD 10.46 Billion in 2024 growing at a CAGR of 10.7% during the forecast period of 2024-2029. Major pharmaceutical companies have ... Read More
-
Global COVID-19 Antibody Detection Kits Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... isothermal nucleic acid amplification) and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for diagnosis and population surveillance. Antibody tests show how many people have had ... Read More
-
Australia & New Zealand Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Specificity, By Technology, By Source, By Application, By End Use, By Country, And Segment Forecasts, 2024 - 2030
... & New Zealand Research Antibodies Market Growth & Trends The Australia & New Zealand research antibodies market size is expected to reach USD 77.6 million by 2030, registering a CAGR of 4.8% from 2024 to ... Read More
-
North America Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, and Others), Nature (Human and Humanized, Chimeric, and Murine), Services (Phage Display, Hybridoma, Transgenic Animal, Single Cell, and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others)
... Cell, and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others) The North America antibody discovery market was valued at US$ 12,98,237.57 million in 2022 and is expected to reach US$ ... Read More
-
Europe Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, and Others), Nature (Human and Humanized, Chimeric, and Murine), Services (Phage Display, Hybridoma, Transgenic Animal, Single Cell, and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others)
... and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others) The Europe antibody discovery market was valued at US$ 8,24,441.11 million in 2022 and is expected to reach US$ 13,29,481.60 million ... Read More
-
Asia Pacific Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, and Others), Nature (Human and Humanized, Chimeric, and Murine), Services (Phage Display, Hybridoma, Transgenic Animal, Single Cell, and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others)
... Cell, and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others) The Asia Pacific antibody discovery market was valued at US$ 6,58,965.05 million in 2022 and is expected to reach US$ ... Read More
-
Antibody Discovery Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global antibody discovery market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global antibody ... Read More
-
Clinical Trials Market Assessment, By Phase [Phase I, Phase II, Phase III, and Phase IV], By Service Type [Laboratory Services, Bioanalytical and Analytical Testing Services, Patient Recruitment and Site Identification, Clinical Trial Data Management Services, Protocol Designing, Medical Device Testing Services, Other Services], By Therapeutic Area [Oncology, Cardiology, Neurology, Infectious Diseases, Other Therapeutic Areas], By Application [Small Molecules, Vaccines, Cell and Gene Therapies, Monoclonal Antibodies, Other Applications], By Study Designs Outlook [Interventional, Observational, Expanded Access], By Sponsor Type [Pharmaceutical Companies, Medical Devices Companies, Academic Institutes], By Region, Opportunities and Forecast, 2017-2031F
... Protocol Designing, Medical Device Testing Services, Other Services], By Therapeutic Area [Oncology, Cardiology, Neurology, Infectious Diseases, Other Therapeutic Areas], By Application [Small Molecules, Vaccines, Cell and Gene Therapies, Monoclonal Antibodies, Other Applications], By Study Designs ... Read More
-
Antibody-Drug Conjugates: Technologies and Global Markets
... this report, market segmentation is based on payload, linker, antibody, indications, and region. The report also discusses current and developing technologies, market projections and market shares. An analysis of clinical trials, innovations, opportunities, and the ... Read More
-
Antibody Drugs: Technologies and Global Markets
... of monoclonal antibodies (mAbs) in human medicine, including the combination of mAbs when attached to cytotoxic agents such as antibody drug conjugates (ADCs). BCC Research analyzed and made projections of each market and its applications, ... Read More
-
European Life Science Tools and Reagents Market
... activities. It looks at the competitive landscape, trends and market dynamics, such as drivers, restraints and opportunities. It also analyzes the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, ... Read More
-
Japan Biosimilars Market, By Product (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-inflammatory Agents, Other), By Application (Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2020-2030F
... By Region, Competition Forecast & Opportunities, 2020-2030F Japan Biosimilars Market was valued at USD 502.09 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.12% through ... Read More
-
Single-Use Bioreactors
... at a CAGR of 15.1% over the analysis period 2023-2030. Single-Use Bioreactor Systems, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$6.1 Billion by the end ... Read More
-
Monoclonal Antibody Therapy Market
... 263.28 billion in 2024 to USD 792.37 billion by 2032, exhibiting a CAGR of 14.8% during the forecast period of 2024-2032. The COVID-19 pandemic boosted several R&D activities in monoclonal antibodies (mAbs) and they experienced ... Read More
-
Global Ophthalmic Disease Therapeutics Market (2024 Edition): Analysis By Indication (Age-related macular degeneration, Diabetic macular edema, Other retinal disorders), By Therapies, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... Azoth Analytics has released a research report titled “Global Ophthalmic Disease Therapeutics Market (2024 Edition)” which provides a Age-related macular degeneration analysis of the Global Ophthalmic Disease Therapeutics industry in terms of market segmentation By ... Read More
-
Serological Transplant Diagnostics
... by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. Reagents & Accessories, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.6 Billion ... Read More
-
2024 Market Report for Research Antibodies
... global life scientists about their usage and purchasing habits for research antibodies! This report, 2024 Market Report for Research Antibodies, will help commercial suppliers make strategic decisions about developing and marketing pre-made catalog antibodies. Highlights ... Read More
Research Assistance
